NIVF
Price
$0.29Alerts
Change
+$0.01 (+3.57%)
Updated
Nov 11 closing price
Capitalization
1.1M
Intraday BUY SELL Signals
UHS
Price
$196.77Alerts
Change
+$1.36 (+0.70%)
Updated
Nov 11 closing price
Capitalization
11.52B
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NIVF vs UHS

NIVF vs UHS Comparison Chart in %
View a ticker or compare two or three
VS
NIVF vs. UHS commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIVF is a Buy and UHS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NIVF with price predictions
Nov 11, 2026

NIVF in +13.24% Uptrend, rising for three consecutive days on October 19, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NIVF advanced for three days, in 67 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NIVF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NIVF entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.041) is normal, around the industry mean (204.532). P/E Ratio (0.000) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.005) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. NIVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for UHS with price predictions
Nov 11, 2026

UHS in +12.12% Uptrend, advancing for three consecutive days on November 05, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UHS advanced for three days, in 240 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on UHS as a result. In 65 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for UHS just turned positive on November 04, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 28 of 43 cases over the following month. The odds of a continued upward trend are 65%.

UHS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for UHS moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In 214 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.

Bearish Trend Analysis

The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 23 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

UHS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.533) is normal, around the industry mean (204.532). P/E Ratio (7.893) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.154) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
UHS: Fundamental Ratings
UHS
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NIVFUHS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
52%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
56%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 7 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 15 days ago
66%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (NIVF: $0.28 vs. UHS: $196.77)
Brand notoriety: NIVF and UHS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: NIVF: 31% vs. UHS: 72%
Market capitalization -- NIVF: $1.1M vs. UHS: $11.52B
NIVF [@Hospital/Nursing Management] is valued at $1.1M. UHS’s [@Hospital/Nursing Management] market capitalization is $11.52B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NIVF’s FA Score shows that 1 FA rating(s) are green while UHS’s FA Score has 0 green FA rating(s).

  • NIVF’s FA Score: 1 green, 4 red.
  • UHS’s FA Score: 0 green, 5 red.
According to our system of comparison, UHS is a better buy in the long-term than NIVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NIVF’s TA Score shows that 2 TA indicator(s) are bullish while UHS’s TA Score has 6 bullish TA indicator(s).

  • NIVF’s TA Score: 2 bullish, 2 bearish.
  • UHS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, UHS is a better buy in the short-term than NIVF.

Price Growth

NIVF (@Hospital/Nursing Management) experienced а -66.71% price change this week, while UHS (@Hospital/Nursing Management) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.65%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +11.07%.

Reported Earning Dates

UHS is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-5.65% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

NIVF and

Correlation & Price change

A.I.dvisor tells us that NIVF and BMGL have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NIVF and BMGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIVF
1D Price
Change %
NIVF100%
+3.18%
BMGL - NIVF
8%
Poorly correlated
-64.56%
UHS - NIVF
7%
Poorly correlated
+0.70%
ASTH - NIVF
7%
Poorly correlated
+2.36%
PIII - NIVF
6%
Poorly correlated
-22.78%
DVA - NIVF
4%
Poorly correlated
+2.35%
More

UHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UHS
1D Price
Change %
UHS100%
+0.70%
HCA - UHS
68%
Closely correlated
+0.32%
THC - UHS
57%
Loosely correlated
+0.93%
CHE - UHS
43%
Loosely correlated
+1.13%
PNTG - UHS
42%
Loosely correlated
+0.16%
ENSG - UHS
41%
Loosely correlated
+0.59%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HBMX19.081.43
+8.10%
Tuttle Capital Concentrated Memory Stack ETF (HBMX)
CVLC94.211.21
+1.30%
Calvert US Large-Cap Core Responsible Index ETF (CVLC)
ITDG42.190.42
+1.01%
iShares LifePath Target Date 2055 ETF (ITDG)
UJAN46.710.31
+0.67%
Innovator U.S. Equity Ultra Buffer ETF - January (UJAN)
IEFA97.430.27
+0.28%
iShares Core MSCI EAFE ETF (IEFA)